BACKGROUND: Altered HLA class I cell surface expression is one of the major mechanisms by which tumor cells escape from T lymphocytes. Immunohistochemistry-defined phenotypes of lost HLA class I expression have been described in human solid tumors, nut less information is available on melanoma cell lines. OBJECTIVES: To describe the frequency and distribution of different types of HLA class I antigen alterations in 91 melanoma cell lines from the European Searchable Tumour Cell and Databank (ESTDAB). METHODS: The HLA class I expression was assessed by flow cytometry and HLA genotyping. RESULTS: We found various types of HLA class I cell surface alterations in about 67% of the melanoma cell lines. These alterations range from total to selective HLA class I loss due to loss of heterozygosity (LOH), haplotype loss, beta2-microglobulin gene mutation, and/or total or selective down-regulation of HLA class I molecules. The most frequently observed phenotype is down-regulation of HLA-B locus that was reversible after treatment with IFN -gamma. CONCLUSIONS: In general, HLA class I alterations in the majority of the cells analyzed were of regulatory nature and could be restored by IFN-gamma. Analysis of the frequency of distinct HLA class I altered phenotypes in these melanoma cell lines revealed specific differences compared to other types of tumors.
BACKGROUND: Altered HLA class I cell surface expression is one of the major mechanisms by which tumor cells escape from T lymphocytes. Immunohistochemistry-defined phenotypes of lost HLA class I expression have been described in humansolid tumors, nut less information is available on melanoma cell lines. OBJECTIVES: To describe the frequency and distribution of different types of HLA class I antigen alterations in 91 melanoma cell lines from the European Searchable Tumour Cell and Databank (ESTDAB). METHODS: The HLA class I expression was assessed by flow cytometry and HLA genotyping. RESULTS: We found various types of HLA class I cell surface alterations in about 67% of the melanoma cell lines. These alterations range from total to selective HLA class I loss due to loss of heterozygosity (LOH), haplotype loss, beta2-microglobulin gene mutation, and/or total or selective down-regulation of HLA class I molecules. The most frequently observed phenotype is down-regulation of HLA-B locus that was reversible after treatment with IFN -gamma. CONCLUSIONS: In general, HLA class I alterations in the majority of the cells analyzed were of regulatory nature and could be restored by IFN-gamma. Analysis of the frequency of distinct HLA class I altered phenotypes in these melanoma cell lines revealed specific differences compared to other types of tumors.
Authors: Hans Klingemann; Carrie Grodman; Elliott Cutler; Marvin Duque; Diane Kadidlo; Andreas K Klein; Kellie A Sprague; Kenneth B Miller; Raymond L Comenzo; Tarun Kewalramani; Neng Yu; Richard A Van Etten; David H McKenna Journal: Transfusion Date: 2012-06-28 Impact factor: 3.157
Authors: Ana Belén García-Ruano; Rosa Méndez; José María Romero; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido Journal: Immunogenetics Date: 2010-09-15 Impact factor: 2.846
Authors: Rafael Carretero; José M Romero; Francisco Ruiz-Cabello; Isabel Maleno; Felix Rodriguez; Francisco M Camacho; Luis M Real; Federico Garrido; Teresa Cabrera Journal: Immunogenetics Date: 2008-06-11 Impact factor: 2.846
Authors: Ji Qian; Hongliang Liu; Sheng Wei; Zhensheng Liu; Yangkai Li; Li-E Wang; Wei V Chen; Christopher I Amos; Jeffrey E Lee; Mark M Iles; Matthew H Law; Anne E Cust; Jennifer H Barrett; Grant W Montgomery; John Taylor; Julia A Newton Bishop; Stuart Macgregor; D Timothy Bishop; Graham J Mann; Nicholas K Hayward; Qingyi Wei Journal: Pigment Cell Melanoma Res Date: 2013-03-27 Impact factor: 4.693
Authors: G Richtig; E Ramelyte; L Koch; H Greinix; S Ferrone; R Dummer; E Richtig Journal: J Eur Acad Dermatol Venereol Date: 2019-05-26 Impact factor: 6.166
Authors: Lorenzo Uccellini; Valeria De Giorgi; Yingdong Zhao; Barbara Tumaini; Narnygerel Erdenebileg; Mark E Dudley; Sara Tomei; Davide Bedognetti; Maria Libera Ascierto; Qiuzhen Liu; Richard Simon; Leah Kottyan; Kenneth M Kaufman; John B Harley; Ena Wang; Steven A Rosenberg; Francesco M Marincola Journal: J Transl Med Date: 2012-08-21 Impact factor: 5.531